These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21412957)

  • 1. Discovery of potent, cyclic calcitonin gene-related peptide receptor antagonists.
    Yan LZ; Johnson KW; Rothstein E; Flora D; Edwards P; Li B; Li J; Lynch R; Vaughn R; Clemens-Smith A; McCarty D; Chow C; McKnight KL; Lu J; Nisenbaum ES; Mayer JP
    J Pept Sci; 2011 May; 17(5):383-6. PubMed ID: 21412957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of novel alpha-Calcitonin Gene-Related Peptide (CGRP) receptor peptide antagonists that are selective for human CGRP receptors.
    Taylor CK; Smith DD; Hulce M; Abel PW
    J Pharmacol Exp Ther; 2006 Nov; 319(2):749-57. PubMed ID: 16873605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of human calcitonin gene-related peptide (CGRP) receptor antagonists. 1. Potent and selective small molecule CGRP antagonists. 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-l-lysyl]-4-(4-pyridinyl)piperazine: the first CGRP antagonist for clinical trials in acute migraine.
    Rudolf K; Eberlein W; Engel W; Pieper H; Entzeroth M; Hallermayer G; Doods H
    J Med Chem; 2005 Sep; 48(19):5921-31. PubMed ID: 16161996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potent, selective, and metabolically stable peptide antagonists to the calcitonin gene-related peptide (CGRP) receptor.
    Miranda LP; Holder JR; Shi L; Bennett B; Aral J; Gegg CV; Wright M; Walker K; Doellgast G; Rogers R; Li H; Valladares V; Salyers K; Johnson E; Wild K
    J Med Chem; 2008 Dec; 51(24):7889-97. PubMed ID: 19053766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine.
    Salvatore CA; Hershey JC; Corcoran HA; Fay JF; Johnston VK; Moore EL; Mosser SD; Burgey CS; Paone DV; Shaw AW; Graham SL; Vacca JP; Williams TM; Koblan KS; Kane SA
    J Pharmacol Exp Ther; 2008 Feb; 324(2):416-21. PubMed ID: 18039958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifications to the N-terminus but not the C-terminus of calcitonin gene-related peptide(8-37) produce antagonists with increased affinity.
    Smith DD; Saha S; Fang G; Schaffert C; Waugh DJ; Zeng W; Toth G; Hulce M; Abel PW
    J Med Chem; 2003 Jun; 46(12):2427-35. PubMed ID: 12773046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synthesis and SAR of calcitonin gene-related peptide (CGRP) receptor antagonists derived from tyrosine surrogates. Part 1.
    Han X; Civiello RL; Conway CM; Cook DA; Davis CD; Macci R; Pin SS; Ren SX; Schartman R; Signor LJ; Thalody G; Widmann KA; Xu C; Chaturvedula PV; Macor JE; Dubowchik GM
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4723-7. PubMed ID: 22727645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcitonin gene-related peptide (CGRP) receptor antagonists: investigations of a pyridinone template.
    Nguyen DN; Paone DV; Shaw AW; Burgey CS; Mosser SD; Johnston V; Salvatore CA; Leonard YM; Miller-Stein CM; Kane SA; Koblan KS; Vacca JP; Graham SL; Williams TM
    Bioorg Med Chem Lett; 2008 Jan; 18(2):755-8. PubMed ID: 18039571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache.
    Edvinsson L
    Cephalalgia; 2004 Aug; 24(8):611-22. PubMed ID: 15265049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization and re-sensitization of CGRP receptor function in human neuroblastoma SK-N-MC cells.
    Pin SS; Xu C; Bahr BA
    Eur J Pharmacol; 2007 Dec; 577(1-3):7-16. PubMed ID: 17825280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor.
    Rist B; Entzeroth M; Beck-Sickinger AG
    J Med Chem; 1998 Jan; 41(1):117-23. PubMed ID: 9438028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally bioavailable imidazoazepanes as calcitonin gene-related peptide (CGRP) receptor antagonists: discovery of MK-2918.
    Paone DV; Nguyen DN; Shaw AW; Burgey CS; Potteiger CM; Deng JZ; Mosser SD; Salvatore CA; Yu S; Roller S; Kane SA; Selnick HG; Vacca JP; Williams TM
    Bioorg Med Chem Lett; 2011 May; 21(9):2683-6. PubMed ID: 21251825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding profile of a selective calcitonin gene-related peptide (CGRP) receptor antagonist ligand, [125I-Tyr]hCGRP8-37, in rat brain and peripheral tissues.
    Van Rossum D; Ménard DP; Fournier A; St-Pierre S; Quirion R
    J Pharmacol Exp Ther; 1994 May; 269(2):846-53. PubMed ID: 8182554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional calcitonin gene-related peptide subtype 2 receptors in porcine coronary arteries are identified as calcitonin gene-related peptide subtype 1 receptors by radioligand binding and reverse transcription-polymerase chain reaction.
    Rorabaugh BR; Scofield MA; Smith DD; Jeffries WB; Abel PW
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1086-94. PubMed ID: 11714898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a nonpeptide antagonist.
    Hasbak P; Saetrum Opgaard O; Eskesen K; Schifter S; Arendrup H; Longmore J; Edvinsson L
    J Pharmacol Exp Ther; 2003 Jan; 304(1):326-33. PubMed ID: 12490608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations in using peptide drugs to characterize calcitonin gene-related peptide receptors.
    Waugh DJ; Bockman CS; Smith DD; Abel PW
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1419-26. PubMed ID: 10336535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the prototype serotonin 5-HT(1B/1D) receptor agonist sumatriptan and the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP(8-37) on myocardial reactive hyperemic response in conscious dogs.
    Lynch JJ; Shen YT; Pittman TJ; Anderson KD; Koblan KS; Gould RJ; Regan CP; Kane SA
    Eur J Pharmacol; 2009 Nov; 623(1-3):96-102. PubMed ID: 19766109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
    Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
    J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues.
    Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
    J Med Chem; 2003 Nov; 46(23):4965-73. PubMed ID: 14584947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent oxadiazole CGRP receptor antagonists for the potential treatment of migraine.
    Nichols PL; Brand J; Briggs M; D'Angeli M; Farge J; Garland SL; Goldsmith P; Hutchings R; Kilford I; Li HY; MacPherson D; Nimmo F; Sanderson FD; Sehmi S; Shuker N; Skidmore J; Stott M; Sweeting J; Tajuddin H; Takle AK; Trani G; Wall ID; Ward R; Wilson DM; Witty D
    Bioorg Med Chem Lett; 2010 Feb; 20(4):1368-72. PubMed ID: 20097071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.